GWN Securities’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
Other funds holding NTLA
GWN Securities's NTLA Position: Q3 2026 in Review
GWN Securities sold out of Intellia Therapeutics (NTLA) in Q3 2026, closing a stake of 35,538 shares — an estimated $601K sold.
GWN Securities first reported a position in NTLA in Q3 2025 and held it in 4 quarters. The position peaked at $601K in Q2 2026. 271 funds tracked by Wall St. Rank hold NTLA as of Q3 2026.
- GWN Securities reported no remaining Intellia Therapeutics position as of Q3 2026 after selling out during the quarter.
- GWN Securities sold 35,538 Intellia Therapeutics shares in Q3 2026, an estimated $601K.
- GWN Securities first reported a position in Intellia Therapeutics in Q3 2025 and held it in 4 quarters.
- GWN Securities's Intellia Therapeutics position peaked at $601K in Q2 2026.
- 271 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q3 2026.
Based on GWN Securities's 13F filing for Q3 2026, filed 12 Nov 2026.